These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease. Villemagne VL; Rowe CC J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919 [TBL] [Abstract][Full Text] [Related]
3. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo? Nordberg A Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1540-3. PubMed ID: 15372212 [No Abstract] [Full Text] [Related]
4. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo? Hardy J Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1539-40. PubMed ID: 15372211 [No Abstract] [Full Text] [Related]
5. [Amyloid-plaque imaging of the brain using PET]. Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182 [TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Kadir A; Marutle A; Gonzalez D; Schöll M; Almkvist O; Mousavi M; Mustafiz T; Darreh-Shori T; Nennesmo I; Nordberg A Brain; 2011 Jan; 134(Pt 1):301-17. PubMed ID: 21149866 [TBL] [Abstract][Full Text] [Related]
7. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease. Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641 [TBL] [Abstract][Full Text] [Related]
8. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients. Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930 [TBL] [Abstract][Full Text] [Related]
9. Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier. André S; Ansciaux E; Saidi E; Larbanoix L; Stanicki D; Nonclercq D; Vander Elst L; Laurent S; Muller RN; Burtea C J Alzheimers Dis; 2017; 60(4):1547-1565. PubMed ID: 29036827 [TBL] [Abstract][Full Text] [Related]
10. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection. Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679 [TBL] [Abstract][Full Text] [Related]
11. [Molecular imaging of Alzheimer's disease]. Albert A; Borbély K Orv Hetil; 2019 Aug; 160(33):1289-1295. PubMed ID: 31401858 [TBL] [Abstract][Full Text] [Related]
12. Technology Insight: imaging amyloid plaques in the living brain with positron emission tomography and MRI. Huddleston DE; Small SA Nat Clin Pract Neurol; 2005 Dec; 1(2):96-105. PubMed ID: 16932505 [TBL] [Abstract][Full Text] [Related]
13. Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies? Moghbel MC; Saboury B; Basu S; Metzler SD; Torigian DA; Långström B; Alavi A Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):202-8. PubMed ID: 22009379 [No Abstract] [Full Text] [Related]
14. Biopsy support for the validity of Pittsburgh compound B positron emission tomography with a twist. Klunk WE Arch Neurol; 2008 Oct; 65(10):1281-3. PubMed ID: 18852340 [No Abstract] [Full Text] [Related]
15. Radiolabeled peptides for Alzheimer's diagnostic imaging: mini review. Barrios-Lopez B; Raki M; Bergström K Curr Radiopharm; 2013 Dec; 6(4):181-91. PubMed ID: 24283961 [TBL] [Abstract][Full Text] [Related]
16. Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography. Klunk WE; Engler H; Nordberg A; Bacskai BJ; Wang Y; Price JC; Bergström M; Hyman BT; Långström B; Mathis CA Neuroimaging Clin N Am; 2003 Nov; 13(4):781-9, ix. PubMed ID: 15024961 [TBL] [Abstract][Full Text] [Related]
17. Amyloid imaging using high-field magnetic resonance. Amatsubo T; Yanagisawa D; Morikawa S; Taguchi H; Tooyama I Magn Reson Med Sci; 2010; 9(3):95-9. PubMed ID: 20885081 [TBL] [Abstract][Full Text] [Related]